Circulating levels of fibroblast growth factor-21 increase with age independently of body composition indices among healthy individuals

Journal of Clinical and Translational Endocrinology

Volumn 2, Issue 2, 2015, Pages 77-82

  Hanks, Lynae J ^a   Gutiérrez, Orlando M ^b   Bamman, Marcas M ^c,d   Ashraf, Ambika ^a   McCormick, Kenneth L ^a   Casazza, Krista ^a  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

Aging; Body composition; Fibroblast growth factor 21

Indexed keywords

FIBROBLAST GROWTH FACTOR 21;

ADULT; AGE; AGING; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; BODY COMPOSITION; BODY FAT DISTRIBUTION; BONE DENSITY; DIET RESTRICTION; ENERGY METABOLISM; FAT MASS; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; TRUNK;

EID: 84929328265     PISSN: None     EISSN: 22146237     Source Type: Journal    
DOI: 10.1016/j.jcte.2015.02.001     Document Type: Article

References (30)

1. Y. Izumiya, H.A. Bina, N. Ouchi, Y. Akasaki, A. Kharitonenkov, and K. Walsh FGF21 is an Akt-regulated myokine FEBS Lett 582 2008 3805 3810
2. P. Hojman, M. Pedersen, A.R. Nielsen, R. Krogh-Madsen, C. Yfanti, and T. Akerstrom Fibroblast growth factor-21 is induced in human skeletal muscles by hyperinsulinemia Diabetes 58 2009 2797 2801
3. A. Kharitonenkov, T.L. Shiyanova, A. Koester, A.M. Ford, R. Micanovic, and E.J. Galbreath FGF-21 as a novel metabolic regulator J Clin Invest 115 2005 1627 1635
4. J.S. Moyers, T.L. Shiyanova, F. Mehrbod, J.D. Dunbar, T.W. Noblitt, and K.A. Otto Molecular determinants of FGF-21 activity-synergy and cross-talk with PPARgamma signaling J Cell Physiol 210 2007 1 6
5. W. Wente, A.M. Efanov, M. Brenner, A. Kharitonenkov, A. Koster, and G.E. Sandusky Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways Diabetes 55 2006 2470 2478
6. M.K. Badman, P. Pissios, A.R. Kennedy, G. Koukos, J.S. Flier, and E. Maratos-Flier Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states Cell Metab 5 2007 426 437
7. Y. Zhang, Y. Xie, E.D. Berglund, K.C. Coate, T.T. He, and T. Katafuchi The starvation hormone, fibroblast growth factor-21, extends lifespan in mice Elife 1 2012 e00065
8. X. Zhang, D.C. Yeung, M. Karpisek, D. Stejskal, Z.G. Zhou, and F. Liu Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans Diabetes 57 2008 1246 1253
9. S. Keipert, M. Ost, K. Johann, F. Imber, M. Jastroch, and E.M. van Schothorst Skeletal muscle mitochondrial uncoupling drives endocrine cross-talk through the induction of FGF21 as a myokine Am J Physiol Endocrinol Metab 306 2014 E469 E482
10. C. Galman, T. Lundasen, A. Kharitonenkov, H.A. Bina, M. Eriksson, and I. Hafström The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man Cell Metab 8 2008 169 174
11. A. Bisgaard, K. Sorensen, T.H. Johannsen, J.W. Helge, A.M. Andersson, and A. Juul Significant gender difference in serum levels of fibroblast growth factor 21 in Danish children and adolescents Int J Pediatr Endocrinol 2014 2014 7
12. L.J. Hanks, A.L. Newton, and K. Casazza Getting to the height of the matter: the relationship between stature and adiposity in pre-pubertal children Ethn Dis 23 2013 71 76
13. L.J. Hanks, K. Casazza, A.P. Ashraf, S. Wallace, and O.M. Gutierrez Fibroblast growth factor-21, body composition, and insulin resistance in pre-pubertal and early pubertal males and females Clin Endocrinol (Oxf) 2014 1-7, [Epub ahead of print]
14. K. Casazza, L.J. Hanks, B. Hidalgo, H.H. Hu, and O. Affuso Short-term physical activity intervention decreases femoral bone marrow adipose tissue in young children: a pilot study Bone 50 2012 23 27
15. A.L. Newton, L.J. Hanks, M. Davis, and K. Casazza The relationships among total body fat, bone mineral content and bone marrow adipose tissue in early-pubertal girls Bonekey Rep 2 2013 315
16. E.K. Merritt, M.J. Stec, A. Thalacker-Mercer, S.T. Windham, J.M. Cross, and D.P. Shelley Heightened muscle inflammation susceptibility may impair regenerative capacity in aging humans JÂ Appl Physiol (1985) 115 2013 937 948
17. C.S. Bickel, J.M. Cross, and M.M. Bamman Exercise dosing to retain resistance training adaptations in young and older adults Med Sci Sports Exerc 43 2011 1177 1187
18. Prevention Centers for Disease Control CDC growth charts 2009
19. L. Guasti, S. Silvennoinen, N.W. Bulstrode, P. Ferretti, U. Sankilampi, and L. Dunkel Elevated FGF21 leads to attenuated postnatal linear growth in preterm infants through GH resistance in chondrocytes J Clin Endocrinol Metab 99 11 2014 Nov E2198 E2206
20. W.X. Jian, W.H. Peng, J. Jin, X.R. Chen, W.J. Fang, and W.X. Wang Association between serum fibroblast growth factor 21 and diabetic nephropathy Metabolism 61 2012 853 859
21. R.D. Semba, K. Sun, J.M. Egan, C. Crasto, O.D. Carlson, and L. Ferrucci Relationship of serum fibroblast growth factor 21 with abnormal glucose metabolism and insulin resistance: the Baltimore longitudinal study of aging J Clin Endocrinol Metab 97 2012 1375 1382
22. N. Itoh FGF21 as a Hepatokine, Adipokine, and Myokine in Metabolism and Diseases Front Endocrinol (Lausanne) 5 2014 107
23. Y. Luo, and W.L. McKeehan Stressed liver and muscle call on adipocytes with FGF21 Front Endocrinol (Lausanne) 4 2013 194
24. W.W. Chen, L. Li, G.Y. Yang, K. Li, X.Y. Qi, and W. Zhu Circulating FGF-21 levels in normal subjects and in newly diagnose patients with type 2 diabetes mellitus Exp Clin Endocrinol Diabetes 116 2008 65 68
25. H. Taniguchi, K. Tanisawa, X. Sun, Z.B. Cao, S. Oshima, and R. Ise Cardiorespiratory fitness and visceral fat are key determinants of serum fibroblast growth factor 21 concentration in Japanese men J Clin Endocrinol Metab 99 10 2014 Oct E1877 E1884
26. Q. Zhang, R.C. Riddle, and T.L. Clemens Bone and the regulation of global energy balance J Intern Med 2015 http://10.1111/joim.12348
27. J.C. Corton, S.P. Anderson, and A. Stauber Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators Annu Rev Pharmacol Toxicol 40 2000 491 518
28. H. Sadie-Van Gijsen, F.S. Hough, and W.F. Ferris Determinants of bone marrow adiposity: the modulation of peroxisome proliferator-activated receptor-gamma2 activity as a central mechanism Bone 56 2013 255 265
29. C.J. Rosen, C. Ackert-Bicknell, J.P. Rodriguez, and A.M. Pino Marrow fat and the bone microenvironment: developmental, functional, and pathological implications Crit Rev Eukaryot Gene Expr 19 2009 109 124
30. C. Jiang, A.T. Ting, and B. Seed PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines Nature 391 1998 82 86